Cantor Fitzgerald Weighs in on Stratasys FY2025 Earnings

Stratasys Ltd. (NASDAQ:SSYS - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Stratasys in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst T. Jensen forecasts that the technology company will post earnings per share of ($0.04) for the year. The consensus estimate for Stratasys' current full-year earnings is ($0.40) per share.

SSYS has been the subject of a number of other reports. Needham & Company LLC raised their price target on Stratasys from $10.00 to $12.00 and gave the company a "buy" rating in a report on Thursday, November 14th. StockNews.com upgraded Stratasys from a "hold" rating to a "buy" rating in a research note on Wednesday, December 25th. Finally, Craig Hallum upped their price target on shares of Stratasys from $12.00 to $15.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $11.40.

Stratasys Stock Performance

Shares of NASDAQ SSYS traded down $0.11 during mid-day trading on Thursday, hitting $9.21. 345,953 shares of the stock were exchanged, compared to its average volume of 406,604. The company has a market cap of $657.41 million, a P/E ratio of -6.98 and a beta of 1.31. Stratasys has a twelve month low of $6.05 and a twelve month high of $14.01. The stock's fifty day simple moving average is $9.41 and its two-hundred day simple moving average is $8.33.

Stratasys (NASDAQ:SSYS - Get Free Report) last announced its earnings results on Wednesday, November 13th. The technology company reported $0.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.04) by $0.05. The business had revenue of $140.00 million during the quarter, compared to analysts' expectations of $139.49 million. Stratasys had a negative net margin of 16.13% and a negative return on equity of 3.75%. The firm's revenue for the quarter was down 13.6% on a year-over-year basis. During the same quarter last year, the company posted ($0.05) EPS.

Hedge Funds Weigh In On Stratasys

Several large investors have recently made changes to their positions in SSYS. Gabelli Funds LLC grew its holdings in Stratasys by 9.0% during the 2nd quarter. Gabelli Funds LLC now owns 193,037 shares of the technology company's stock worth $1,620,000 after acquiring an additional 16,000 shares during the period. Clearline Capital LP acquired a new stake in shares of Stratasys during the second quarter worth $9,301,000. Pinnacle Associates Ltd. increased its holdings in Stratasys by 0.4% in the third quarter. Pinnacle Associates Ltd. now owns 1,050,639 shares of the technology company's stock valued at $8,731,000 after purchasing an additional 3,791 shares during the last quarter. ARK Investment Management LLC lifted its stake in Stratasys by 0.7% in the third quarter. ARK Investment Management LLC now owns 647,221 shares of the technology company's stock valued at $5,378,000 after buying an additional 4,589 shares during the period. Finally, RPG Investment Advisory LLC boosted its holdings in Stratasys by 29.6% during the third quarter. RPG Investment Advisory LLC now owns 659,996 shares of the technology company's stock worth $5,485,000 after buying an additional 150,891 shares during the last quarter. Institutional investors and hedge funds own 75.77% of the company's stock.

About Stratasys

Stratasys Ltd. provides connected polymer-based 3D printing solutions. It offers range of 3D printing systems, which includes polyjet printer, Fused Deposition Modeling (FDM) printers, stereolithography printing systems, origin P3 printers, and selective absorption fusion printer for additive manufacturing, and tooling and rapid prototyping for various vertical markets, such as automotive, aerospace, consumer products and healthcare.